A strategy to improve current MSC-based therapies (TECH1P.83…

Emerging

0
Citations
0
Refs
2014
Year
Search Works
Work Details
  • DOI 10.4049/jimmunol.192.supp.69.1
  • OpenAlex ID W1537778587
  • Type Conference-abstract
  • Language EN
  • Published 01 May 2014
  • Volume 192 (Supplement_1)
  • Pages 69.1
  • Source The Journal of Immunology
  • Publisher American Association of Immunologis…
  • Countries 1
  • Institutions 1
  • Added 10 Oct 2025
  • Updated 21 Aug 2026
External Links
OpenAlex Record DOI Resolver
MENU
0

A strategy to improve current MSC-based therapies (TECH1P.833)

Conference-abstract 2014 EN

Abstract Mesenchymal stem cell (MSC) hold promise in the therapy of many inflammatory and degenerative disease. However, result from recent clinical trials using these cells are disappointing, suggesting that current MSC-based therapies need to be improved. We previously demonstrated that, immediately after their contact with serum following infusion, MSCs active complement of the innate immunity…

0

Citations

0

References

2

Authors

0.00

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
2 authors
#AuthorInstitutionsORCID
1 Yan Li Cleveland Clinic (US)
2 Feng Lin Cleveland Clinic (US)
Related Works
10

Data: OpenAlex